English

ELECTROPHARMACOLOGY INC

EDGAR

Quarterly report (10-Q) · filed 2001-08-27

38 filing records in this dataset, filed from 1996-05-14 to 2001-08-27. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2001-06-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

0 USD

2001-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -99710 USD Source
Operating Cash Flow: -99710 USD Source

Free cash flow

0 USD

2001-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -99710 USD Source
Operating Cash Flow: -99710 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 0 USD 2001-06-30 Source
Exact value

0 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

180 thousand USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Revenue: 59765 USD · 2000-07-01 – 2000-09-30 Source
Revenue: 396242 USD · 2000-01-01 – 2000-12-31 Source
Revenue: 276458 USD · 2000-01-01 – 2000-09-30 Source
Revenue: 0 USD · 2001-01-01 – 2001-03-31 Source
Revenue: 0 USD · 2001-04-01 – 2001-06-30 Source

Net income

-698 thousand USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Net income: -654201 USD · 2000-07-01 – 2000-09-30 Source
Net income: -1369364 USD · 2000-01-01 – 2000-12-31 Source
Net income: -1675134 USD · 2000-01-01 – 2000-09-30 Source
Net income: -51478 USD · 2001-01-01 – 2001-03-31 Source
Net income: -297591 USD · 2001-04-01 – 2001-06-30 Source

Operating cash flow

-74.9 thousand USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Operating cash flow: -310345 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -321006 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -296212 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -310345 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -99710 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -99710 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -99710 USD · 2001-01-01 – 2001-03-31 Source

Capital expenditure

0 USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Capital expenditure: 0 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 0 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 0 USD · 2000-01-01 – 2000-12-31 Source
Capital expenditure: 0 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 0 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 0 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 0 USD · 2001-01-01 – 2001-03-31 Source

Free cash flow

-74.9 thousand USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Operating cash flow: -310345 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -321006 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -296212 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -310345 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -99710 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -99710 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -99710 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 0 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 0 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 0 USD · 2000-01-01 – 2000-12-31 Source
Capital expenditure: 0 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 0 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 0 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 0 USD · 2001-01-01 – 2001-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-08-27.

Financial data available through: 2000-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2000-12-31
Operating income: 6 of 11 periods available· newest 2000-12-31
Net income: 6 of 11 periods available· newest 2000-12-31
Operating cash flow: 6 of 11 periods available· newest 2000-12-31
Capital expenditure: 6 of 11 periods available· newest 2000-12-31
Total assets: 5 of 11 periods available· newest 1999-12-31
Total liabilities: 5 of 11 periods available· newest 1999-12-31
Current assets: 6 of 11 periods available· newest 2000-12-31
Current liabilities: 6 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-22.8%

Prior period

USD 513,021

1999-01-01 – 1999-12-31
Current period

USD 396,242

2000-01-01 – 2000-12-31

Exact inputs and evidence

396242 − 513021 = -116779 USD

513021 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
396242 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Year-over-year change in Revenue: -116779 USD Concept: fundies:Revenue Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 396242 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#687 Input fundies:Revenue: 513021 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#687
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 679,783

Prior period

−USD 2.05 million

1999-01-01 – 1999-12-31
Current period

−USD 1.37 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-1369364 − -2049147 = 679783 USD

-2049147 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-1369364 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Year-over-year change in Net income: 679783 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1369364 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#820 Input fundies:NetIncome: -2049147 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#820
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.21 million

Prior period

−USD 1.51 million

1999-01-01 – 1999-12-31
Current period

−USD 296,212

2000-01-01 – 2000-12-31

Exact inputs and evidence

-296212 − -1509463 = 1213251 USD

-1509463 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-296212 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Year-over-year change in Operating cash flow: 1213251 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -296212 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#840 Input fundies:OperatingCashFlow: -1509463 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#840
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 42,747

1999-01-01 – 1999-12-31
Current period

USD 0

2000-01-01 – 2000-12-31

Exact inputs and evidence

0 − 42747 = -42747 USD

42747 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
0 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Year-over-year change in Capital expenditure: -42747 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#843 Input fundies:CapitalExpenditure: 42747 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#843
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 2000-01-01 – 2000-12-31

Revenue USD 396,242 100% of revenue
Cost of revenue USD 262,989 66% of revenue
Operating expenses USD 1.28 million 322% of revenue
Operating income −USD 1.14 million −288% of revenue
Tax, interest and other Derived USD 227,545 57% of revenue
Net income −USD 1.37 million −346% of revenue

Cash

Operating cash flow −USD 296,212 −75% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 296,212 −75% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Operating loss: operating costs were 237% of revenue.
1996 Operating loss: operating costs were 244% of revenue.
1997 Operating loss: operating costs were 167% of revenue.
1998 Operating loss: operating costs were 2,896% of revenue.
1999 Operating loss: operating costs were 564% of revenue.
2000 Operating loss: operating costs were 388% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	1996663	4727707 Derived	-2731044	338542 Derived	-3069586	-3362136 Derived	Source 1995-01-01 – 1995-12-31: 1996663 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -2731044 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -3069586 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -3193078 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 169058 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	2105762	5133154 Derived	-3027392	-99402 Derived	-2927990	-2662766 Derived	Source 1996-01-01 – 1996-12-31: 2105762 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -3027392 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -2927990 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -2630218 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 32548 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	2401249	4003419 Derived	-1602170	45747 Derived	-1647917	99339 Derived	Source 1997-01-01 – 1997-12-31: 2401249 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -1602170 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -1647917 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 99339 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 0 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	620484	17968920 Derived	-17348436	-2673003 Derived	-14675433	-858500 Derived	Source 1998-01-01 – 1998-12-31: 620484 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -17348436 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -14675433 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -816806 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 41694 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	513021	2891363 Derived	-2378342	-329195 Derived	-2049147	-1552210 Derived	Source 1999-01-01 – 1999-12-31: 513021 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -2378342 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -2049147 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -1509463 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 42747 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	396242	1538061 Derived	-1141819	227545 Derived	-1369364	-296212 Derived	Source 2000-01-01 – 2000-12-31: 396242 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -1141819 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -1369364 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -296212 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 396.2K 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	1996663	Revenue: 1996663 Open source
19961996-12-31	Revenue	2105762	Revenue: 2105762 Open source
19971997-12-31	Revenue	2401249	Revenue: 2401249 Open source
19981998-12-31	Revenue	620484	Revenue: 620484 Open source
19991999-12-31	Revenue	513021	Revenue: 513021 Open source
20002000-12-31	Revenue	396242	Revenue: 396242 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-22.8% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 1996663 Open source
19961996-12-31	Year over year	5.5%	Revenue: 2105762 Open source Revenue: 1996663 Open source
19971997-12-31	Year over year	14%	Revenue: 2401249 Open source Revenue: 2105762 Open source
19981998-12-31	Year over year	-74.2%	Revenue: 620484 Open source Revenue: 2401249 Open source
19991999-12-31	Year over year	-17.3%	Revenue: 513021 Open source Revenue: 620484 Open source
20002000-12-31	Year over year	-22.8%	Revenue: 396242 Open source Revenue: 513021 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -288.2% 2000

Net margin -345.6% 2000

Free cash flow margin -74.8% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	-136.8%	Operating Income: -2731044 Open source Revenue: 1996663 Open source
19961996-12-31	Operating margin	-143.8%	Operating Income: -3027392 Open source Revenue: 2105762 Open source
19971997-12-31	Operating margin	-66.7%	Operating Income: -1602170 Open source Revenue: 2401249 Open source
19981998-12-31	Operating margin	-2,796%	Operating Income: -17348436 Open source Revenue: 620484 Open source
19991999-12-31	Operating margin	-463.6%	Operating Income: -2378342 Open source Revenue: 513021 Open source
20002000-12-31	Operating margin	-288.2%	Operating Income: -1141819 Open source Revenue: 396242 Open source
19951995-12-31	Net margin	-153.7%	Net Income: -3069586 Open source Revenue: 1996663 Open source
19961996-12-31	Net margin	-139%	Net Income: -2927990 Open source Revenue: 2105762 Open source
19971997-12-31	Net margin	-68.6%	Net Income: -1647917 Open source Revenue: 2401249 Open source
19981998-12-31	Net margin	-2,365.2%	Net Income: -14675433 Open source Revenue: 620484 Open source
19991999-12-31	Net margin	-399.4%	Net Income: -2049147 Open source Revenue: 513021 Open source
20002000-12-31	Net margin	-345.6%	Net Income: -1369364 Open source Revenue: 396242 Open source
19951995-12-31	Free cash flow margin	-168.4%	Revenue: 1996663 Open source Operating Cash Flow: -3193078 Open source Capital Expenditure: 169058 Open source
19961996-12-31	Free cash flow margin	-126.5%	Revenue: 2105762 Open source Operating Cash Flow: -2630218 Open source Capital Expenditure: 32548 Open source
19971997-12-31	Free cash flow margin	4.1%	Revenue: 2401249 Open source Operating Cash Flow: 99339 Open source Capital Expenditure: 0 Open source
19981998-12-31	Free cash flow margin	-138.4%	Revenue: 620484 Open source Operating Cash Flow: -816806 Open source Capital Expenditure: 41694 Open source
19991999-12-31	Free cash flow margin	-302.6%	Revenue: 513021 Open source Operating Cash Flow: -1509463 Open source Capital Expenditure: 42747 Open source
20002000-12-31	Free cash flow margin	-74.8%	Revenue: 396242 Open source Operating Cash Flow: -296212 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -296.2K 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-3193078	Operating Cash Flow: -3193078 Open source
19961996-12-31	Operating cash flow	-2630218	Operating Cash Flow: -2630218 Open source
19971997-12-31	Operating cash flow	99339	Operating Cash Flow: 99339 Open source
19981998-12-31	Operating cash flow	-816806	Operating Cash Flow: -816806 Open source
19991999-12-31	Operating cash flow	-1509463	Operating Cash Flow: -1509463 Open source
20002000-12-31	Operating cash flow	-296212	Operating Cash Flow: -296212 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -296.2K 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-3362136	Operating Cash Flow: -3193078 Open source Capital Expenditure: 169058 Open source
19961996-12-31	Free cash flow	-2662766	Operating Cash Flow: -2630218 Open source Capital Expenditure: 32548 Open source
19971997-12-31	Free cash flow	99339	Operating Cash Flow: 99339 Open source Capital Expenditure: 0 Open source
19981998-12-31	Free cash flow	-858500	Operating Cash Flow: -816806 Open source Capital Expenditure: 41694 Open source
19991999-12-31	Free cash flow	-1552210	Operating Cash Flow: -1509463 Open source Capital Expenditure: 42747 Open source
20002000-12-31	Free cash flow	-296212	Operating Cash Flow: -296212 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

1,610.2% 1999

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Liabilities / assets	17.7%	Total Liabilities: 864793 Open source Total Assets: 4877180 Open source
19961996-12-31	Liabilities / assets	45.1%	Total Liabilities: 998705 Open source Total Assets: 2213080 Open source
19971997-12-31	Liabilities / assets	105.2%	Total Liabilities: 1518478 Open source Total Assets: 1443542 Open source
19981998-12-31	Liabilities / assets	72.1%	Total Liabilities: 2279404 Open source Total Assets: 3161331 Open source
19991999-12-31	Liabilities / assets	1,610.2%	Total Liabilities: 11133779 Open source Total Assets: 691453 Open source
2000-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	4.38×	Current Assets: 3660950 Open source Current Liabilities: 836760 Open source
19961996-12-31	Current assets / current liabilities	1.19×	Current Assets: 1188206 Open source Current Liabilities: 995369 Open source
19971997-12-31	Current assets / current liabilities	0.41×	Current Assets: 622946 Open source Current Liabilities: 1518478 Open source
19981998-12-31	Current assets / current liabilities	1.2×	Current Assets: 2687186 Open source Current Liabilities: 2233865 Open source
19991999-12-31	Current assets / current liabilities	0.16×	Current Assets: 348128 Open source Current Liabilities: 2157618 Open source
20002000-12-31	Current assets / current liabilities	0×	Current Assets: 6764 Open source Current Liabilities: 2801410 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	−USD 3.07 million Exact value Exact value: -3069586 USD 1995-01-01 – 1995-12-31: -3069586 USD Inspect Net Income Open source Share or cite Citation for Net Income · ELECTROPHARMACOLOGY INC · 1995-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Net Income: -3069586 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3069586 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000912057-97-028387.txt#678 The citation records this snapshot. The page link may show a newer release later.	−USD 3.19 million Exact value Exact value: -3193078 USD 1995-01-01 – 1995-12-31: -3193078 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ELECTROPHARMACOLOGY INC · 1995-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Operating Cash Flow: -3193078 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3193078 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000912057-97-028387.txt#699 The citation records this snapshot. The page link may show a newer release later.	USD 169,058 Exact value Exact value: 169058 USD 1995-01-01 – 1995-12-31: 169058 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ELECTROPHARMACOLOGY INC · 1995-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Capital Expenditure: 169058 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 169058 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000912057-97-028387.txt#702 The citation records this snapshot. The page link may show a newer release later.	−USD 3.36 million Calculation and evidence -3193078 − 169058 USD Exact free cash flow: -3362136 USD 1995-01-01 – 1995-12-31: -3193078 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 169058 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ELECTROPHARMACOLOGY INC · 1995-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Free cash flow: -3362136 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3193078 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000912057-97-028387.txt#699 Input fundies:CapitalExpenditure: 169058 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000912057-97-028387.txt#702 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 2.93 million Exact value Exact value: -2927990 USD 1996-01-01 – 1996-12-31: -2927990 USD Inspect Net Income Open source Share or cite Citation for Net Income · ELECTROPHARMACOLOGY INC · 1996-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Net Income: -2927990 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2927990 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2367 The citation records this snapshot. The page link may show a newer release later.	−USD 2.63 million Exact value Exact value: -2630218 USD 1996-01-01 – 1996-12-31: -2630218 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ELECTROPHARMACOLOGY INC · 1996-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Operating Cash Flow: -2630218 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2630218 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2394 The citation records this snapshot. The page link may show a newer release later.	USD 32,548 Exact value Exact value: 32548 USD 1996-01-01 – 1996-12-31: 32548 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ELECTROPHARMACOLOGY INC · 1996-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Capital Expenditure: 32548 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 32548 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2397 The citation records this snapshot. The page link may show a newer release later.	−USD 2.66 million Calculation and evidence -2630218 − 32548 USD Exact free cash flow: -2662766 USD 1996-01-01 – 1996-12-31: -2630218 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 32548 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ELECTROPHARMACOLOGY INC · 1996-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Free cash flow: -2662766 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2630218 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2394 Input fundies:CapitalExpenditure: 32548 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2397 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 1.65 million Exact value Exact value: -1647917 USD 1997-01-01 – 1997-12-31: -1647917 USD Inspect Net Income Open source Share or cite Citation for Net Income · ELECTROPHARMACOLOGY INC · 1997-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Net Income: -1647917 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1647917 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2367 The citation records this snapshot. The page link may show a newer release later.	USD 99,339 Exact value Exact value: 99339 USD 1997-01-01 – 1997-12-31: 99339 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ELECTROPHARMACOLOGY INC · 1997-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Operating Cash Flow: 99339 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 99339 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2394 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1997-01-01 – 1997-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ELECTROPHARMACOLOGY INC · 1997-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2397 The citation records this snapshot. The page link may show a newer release later.	USD 99,339 Calculation and evidence 99339 − 0 USD Exact free cash flow: 99339 USD 1997-01-01 – 1997-12-31: 99339 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ELECTROPHARMACOLOGY INC · 1997-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Free cash flow: 99339 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 99339 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2394 Input fundies:CapitalExpenditure: 0 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001024739-98-000391.txt#2397 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 14.68 million Exact value Exact value: -14675433 USD 1998-01-01 – 1998-12-31: -14675433 USD Inspect Net Income Open source Share or cite Citation for Net Income · ELECTROPHARMACOLOGY INC · 1998-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Net Income: -14675433 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14675433 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000934849-00-000007.txt#643 The citation records this snapshot. The page link may show a newer release later.	−USD 816,806 Exact value Exact value: -816806 USD 1998-01-01 – 1998-12-31: -816806 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ELECTROPHARMACOLOGY INC · 1998-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Operating Cash Flow: -816806 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -816806 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000934849-00-000007.txt#672 The citation records this snapshot. The page link may show a newer release later.	USD 41,694 Exact value Exact value: 41694 USD 1998-01-01 – 1998-12-31: 41694 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ELECTROPHARMACOLOGY INC · 1998-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Capital Expenditure: 41694 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 41694 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000934849-00-000007.txt#675 The citation records this snapshot. The page link may show a newer release later.	−USD 858,500 Calculation and evidence -816806 − 41694 USD Exact free cash flow: -858500 USD 1998-01-01 – 1998-12-31: -816806 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 41694 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ELECTROPHARMACOLOGY INC · 1998-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Free cash flow: -858500 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -816806 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000934849-00-000007.txt#672 Input fundies:CapitalExpenditure: 41694 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0000934849-00-000007.txt#675 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 2.05 million Exact value Exact value: -2049147 USD 1999-01-01 – 1999-12-31: -2049147 USD Inspect Net Income Open source Share or cite Citation for Net Income · ELECTROPHARMACOLOGY INC · 1999-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Net Income: -2049147 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2049147 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#820 The citation records this snapshot. The page link may show a newer release later.	−USD 1.51 million Exact value Exact value: -1509463 USD 1999-01-01 – 1999-12-31: -1509463 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ELECTROPHARMACOLOGY INC · 1999-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Operating Cash Flow: -1509463 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1509463 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#840 The citation records this snapshot. The page link may show a newer release later.	USD 42,747 Exact value Exact value: 42747 USD 1999-01-01 – 1999-12-31: 42747 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ELECTROPHARMACOLOGY INC · 1999-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Capital Expenditure: 42747 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42747 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#843 The citation records this snapshot. The page link may show a newer release later.	−USD 1.55 million Calculation and evidence -1509463 − 42747 USD Exact free cash flow: -1552210 USD 1999-01-01 – 1999-12-31: -1509463 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 42747 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ELECTROPHARMACOLOGY INC · 1999-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Free cash flow: -1552210 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1509463 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#840 Input fundies:CapitalExpenditure: 42747 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#843 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 1.37 million Exact value Exact value: -1369364 USD 2000-01-01 – 2000-12-31: -1369364 USD Inspect Net Income Open source Share or cite Citation for Net Income · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Net Income: -1369364 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1369364 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#820 The citation records this snapshot. The page link may show a newer release later.	−USD 296,212 Exact value Exact value: -296212 USD 2000-01-01 – 2000-12-31: -296212 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Operating Cash Flow: -296212 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -296212 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#840 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2000-01-01 – 2000-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#843 The citation records this snapshot. The page link may show a newer release later.	−USD 296,212 Calculation and evidence -296212 − 0 USD Exact free cash flow: -296212 USD 2000-01-01 – 2000-12-31: -296212 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ELECTROPHARMACOLOGY INC · 2000-12-31 ELECTROPHARMACOLOGY INC (edgar:934849) Free cash flow: -296212 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/934849?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -296212 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#840 Input fundies:CapitalExpenditure: 0 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934849/0001046532-01-500121.txt#843 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

38 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000934849, 934849, edgar:934849

ELECTROPHARMACOLOGY INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2000 2000-01-01 – 2000-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation